Anti-epileptic drugs and hormonal treatments

Current Treatment Options in Neurology

Volumn 16, Issue 5, 2014, Pages

  Johnston, Clare A ^a   Crawford, Pamela M ^a  

^a YORK HOSPITAL   (United Kingdom)

Author keywords

Anti epileptic drugs; Benzodiazepines; Carbamazepine; Contraception; Contraceptive implant; Epilepsy; Eslicarbazepine; Ethosuximide; Gabapentin; Hormones; Intra uterine contraceptive device; Lamotrigine; Levonorgestrel implants; Medroxyprogesterone; Norethisterone; Oral contraceptive pill; Oxcarbazepine; Perampanel; Phenobarbitone; Phenytoin; Pregabalin; Sodium valproate; Tiagabine; Topiramate; Zonisamide

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CONTRACEPTIVE AGENT; DESOGESTREL; ESLICARBAZEPINE; ETHINYLESTRADIOL; ETIRACETAM; GABAPENTIN; GESTAGEN; HARKOSERIDE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ENANTATE; OXCARBAZEPINE; PERAMPANEL; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; PROGESTERONE; TIAGABINE; ULIPRISTAL; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ACUTE INTERMITTENT PORPHYRIA; AREA UNDER THE CURVE; ARTERY THROMBOSIS; ARTICLE; BARRIER CONTRACEPTION; BREAST CANCER; BREAST FEEDING; CONTRACEPTION; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG EXPOSURE; EMERGENCY CONTRACEPTION; ENZYME INDUCTION; EPILEPSY; GALLSTONE; HORMONAL CONTRACEPTION; HORMONAL THERAPY; HUMAN; HYDROXYLATION; INTRAUTERINE CONTRACEPTIVE DEVICE; LIVER DISEASE; MEDICAL ETHICS; MEDICATION COMPLIANCE; MENSTRUAL CYCLE; METRORRHAGIA; MIGRAINE WITH AURA; PRACTICE GUIDELINE; VAGINA BLEEDING; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 84896691584     PISSN: 10928480     EISSN: 15343138     Source Type: Journal    
DOI: 10.1007/s11940-014-0288-3     Document Type: Article

References (41)

1. Moreau C, Trussell J, Rodriguez G, et al. Contraceptive failure rates in France: results from a population-based survey. J Hum Reprod. 2007;22(9):2422-7. (Pubitemid 47289056)
2. •• Brodie MJ, Mintzer S, Pack AM, et al. Enzyme induction with antiepileptic drugs: cause for concern? Epilepsia. 2013;54(1):11-27. An interesting review considering the potential clinical implications of the hepatic enzyme inducing effects of antiepileptic drugs.
3. Perucca E, Tomson T. The pharmacological treatment of epilepsy in adults. Lancet Neurol. 2011;10:446-56.
4. •• Brodie MJ, Kwan P. Newer drugs for focal epilepsy in adults. BMJ. 2012;344:e345. Review of the newer drugs used for the treatment of epilepsy.
5. •• Faculty of Sexual and Reproductive Healthcare Clinical Effectiveness Statement. Update on newer antiepileptic and antiretroviral drugs and interactions with hormonal contraceptives. 2013. Available at: http://www.fsrh.org/pdfs/ CEUstatementUpdateNewerAntiepilepticAntiretroviralDrugs.pdf Accessed December 21, 2013. Updated hormonal contraceptive guidelines detailing potential interactions with newer anti-epileptic drugs.
6. Christensen J, Petrenaite V, Atterman J, et al. Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial. Epilepsia. 2007;48:484-9. (Pubitemid 46365201)
7. Sabers A, Öhman I, Christensen J, et al. Oral contraceptives reduce lamotrigine plasma levels. Neurology. 2003;61:570-1. (Pubitemid 37025386)
8. Reimers A, Helde G, Brodtkorb E. Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations. Epilepsia. 2005;46(9):342-8.
9. Sidhu J, Job S, Singh S, Philipson R. The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects. Br J Clin Pharmacol. 2006;61:191-9. (Pubitemid 43382612)
10. Galimberti CA, Mazzucchelli I, Arbazino C, et al. Increased apparent oral clearance of valproate acid during intake of combined contraceptive steroids in women with epilepsy. Epilepsia. 2006;47:1569-72. (Pubitemid 44393871)
11. Perucca E, Hedges A, Makki KA, et al. A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in antiepileptic patients. Br J Pharmacol. 1984;11:533-9.
12. Tomson T, Svensson J, Hilton-Brown P. Relationship of inter-individual dose to plasma concentration of carbamazepine: indication of dose-dependent induction of metabolism. Ther Drug Monit. 1989;11:533-9. (Pubitemid 19232948)
13. Bertz RJ, Granneman GR. Use of in vitro and in vivo data to estimate likelihood of metabolic pharmacodynamic interactions. Clin Pharmacokinet. 1997;32:210-58. (Pubitemid 27122521)
14. Wright SA, Stevens JC. The human hepatic cytochromes 450 involved in drug metabolism. Crit Rev Toxicol. 1992;22:1-21.
15. Levy RH. Cytochrome P450 isoenzymes and antiepileptic drug interactions. Epilepsia. 1995;36 Suppl 5:S8-S13.
16. Levy RH, Bishop F, Streeter AJ. Explanation and prediction of drug interactions with topiramate using CYP450 inhibition spectrum. Epilepsia. 1995;36 Suppl 4:47-51.
17. Davis AR, Westhoff CL, Stanczyk FZ. Carbamazepine coadministration with an oral contraceptive: effects on steroid pharmacokinetics, ovulation and bleeding. Epilepsia. 2011;52(2):243-7.
18. Giuliano RA, Hiersemenzel E, Baltes G. Influence of a new antiepileptic drug (Levetiracetam, ucbLO59) on the pharmacokinetics and pharmacodynamics of oral contraceptives. Epilepsia. 1996;37 Suppl 4:90.
19. Eldon MA, Underwood BA, Randinitis EJ, et al. Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol. Neurology. 1998;50:1146-8. (Pubitemid 28212855)
20. Bockbrader HN, Posvar EL, Hunt T. Pharmacokinetics of pregabalin and a concomitantly administered oral contraceptive shows no drug-drug interaction. Epilepsia. 2004;45 Suppl 3:153.
21. Bartoli A, Gatti G, Cipolla G, et al. A double-blind placebo-controlled study on the effect of vigabatrin on in vivo parameters of hepatic microsomal enzyme induction and on the kinetics of steroid oral contraceptives in healthy female volunteers. Epilepsia. 1997;38:702-7.
22. Mengel HB, Houston A, Back DJ. An evaluation of the interaction between tiagabine and oral contraceptives in female volunteers. J Pharm Med. 1994;4:141-50. (Pubitemid 24301554)
23. Griffith SG, Dai Y. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women. Clin Ther. 2004;12:2056-65. (Pubitemid 40353615)
24. Nakasa H, Nakamura H, Ono S, et al. Prediction of drug-drug interactions of zonisamide in humans from in vitro data. Eur J Clin Pharmacol. 1998;54(2):177-83. (Pubitemid 28204274)
25. Cawello W, Rosenkranz B, Schmid B, et al. Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers. Epilepsia. 2013;54(3):530-6.
26. Crawford P, Chadwick D, Cleland P, et al. The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptives. Contraception. 1986;33:23-9. (Pubitemid 16133449)
27. Crawford P, Chadwick D, Martin C, et al. The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids. Br J Clin Pharmacol. 1990;30:892-6.
28. Crawford P. Interactions between antiepileptic drugs and hormonal contraception. CNS Drugs. 2002;16:263-72. (Pubitemid 34492933)
29. Back DJ, Bates M, Bowden A, et al. The interactions of phenobarbital and other anticonvulsants with oral contraceptive therapy. Contraception. 1980;22:495-503. (Pubitemid 11213680)
30. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: management issues for women with epilepsy (summary statement). Epilepsia. 1998;39:1226-31.
31. Guillebaud J. Drug interactions with hormonal contraception. J Fam Plan Reprod Health Care. 2005;31:335-6.
32. Marsh M, Kumar U. Practical recommendations for contraception. In: Panayiatopolis CP, Crawford PM, Thomson T, editors. Educational kit on epilepsies, vol 4, epilepsy and women. Oxford: Medicinae; 2008. p. 96-104.
33. • Faculty of Sexual and Reproductive Healthcare Clinical Effectiveness Unit. Clinical guidance: drug interactions with hormonal contraception. 2011. Available at: http://www.fsrh.org/pdfs/ CEUGuidanceDrugInteractionsHormonal.pdf Accessed December 21, 2013. Hormonal contraceptive guidelines detailing potential interactions with anti-epileptic drugs.
34. Betts T, Crawford P. Women and epilepsy. London: Martin Dunitz; 1998.
35. O 'Brien M, Guillebaud J. Contraception for women with epilepsy. Epilepsia. 2006;47(9):1419-22.
36. Pharmacia Limited. Depo-Provera 150 mg/mL injection: Summary of Product Characteristics (SPC). 2007. Available at: http://www.medicines.org.uk/emc Accessed December 22, 2013.
37. Walsh JS, Eastell R, Peel NF. Effects of depot medroxyprogesterone acetate on bone density and bone metabolism before and after peak bone mass: a case-control study. J Clin Endocrinol Metab. 2008;93:1317-23. (Pubitemid 351519727)
38. Haukkamaa M. Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant therapy. Contraception. 1986;33:559-65. (Pubitemid 16014482)
39. Schindlbeck C, Janni W, Friese K. Failure of Implanon contraception in a patient taking carbamazepine for epilepsy. Arch Gynecol Obstet. 2006;273:255-6. (Pubitemid 43004702)
40. HRA Pharma UK Ltd. ellaOne: Summary of Product Characteristics. 2010. Available at: http://www.medicines.org/emc Accessed December 21, 2013.
41. Bounds W, Guillebaud J. Observational series on women using the contraceptive Mirena concurrently with anti-epileptic and other enzyme-inducing drugs. J Fam Plan Reprod Health Care. 2002;28:78-80. (Pubitemid 34595936)